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Abstract
Human pluripotent stem cells (hPSCs) are a powerful tool for modelling human development. In recent years, hPSCs have
become central in cell-based therapies for neurodegenerative diseases given their potential to replace affected neurons. However,
directing hPSCs into specific neuronal types is complex and requires an accurate protocol that mimics endogenous neuronal
development. Here we describe step-by-step a fast feeder-free neuronal differentiation protocol to direct hPSCs to mature
forebrain neurons in 37 days in vitro (DIV). The protocol is based upon a combination of specific morphogens, trophic and
growth factors, ions, neurotransmitters and extracellular matrix elements. A human-induced PSC line (Ctr-Q33) and a human
embryonic stem cell line (GEN-Q18) were used to reinforce the potential of the protocol. Neuronal activity was analysed by
single-cell calcium imaging. At 8 DIV, we obtained a homogeneous population of hPSC-derived neuroectodermal progenitors
which self-arranged in bi-dimensional neural tube-like structures. At 16 DIV, we generated hPSC-derived neural progenitor cells
(NPCs) with mostly a subpallial identity along with a subpopulation of pallial NPCs. Terminal in vitro neuronal differentiation
was confirmed by the expression of microtubule associated protein 2b (Map 2b) by almost 100% of hPSC-derived neurons and
the expression of specific-striatal neuronal markers including GABA, CTIP2 and DARPP-32. HPSC-derived neurons showed
mature and functional phenotypes as they expressed synaptic markers, voltage-gated ion channels and neurotransmitter receptors.
Neurons displayed diverse spontaneous activity patterns that were classified into three major groups, namely “high”,
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“intermediate” and “low” firing neurons. Finally, transplantation experiments showed that the NPCs survived and differentiated
within mouse striatum for at least 3 months. NPCs integrated host environmental cues and differentiated into striatal medium-
sized spiny neurons (MSNs), which successfully integrated into the endogenous circuitry without teratoma formation.
Altogether, these findings demonstrate the potential of this robust human neuronal differentiation protocol, which will bring
new opportunities for the study of human neurodevelopment and neurodegeneration, and will open new avenues in cell-based
therapies, pharmacological studies and alternative in vitro toxicology.
Keywords Telencephalon . Neuronal differentiation . Striatum . Calcium imaging . Spike-inference analysis . Transplantation
Introduction
Neurogenesis is a complex and highly regulated process directed
by evolutionary conserved signalling molecules [1]. Despite in-
tensive research, many aspects of neurogenesis and
neurodevelopment remain to be elucidated. Furthermore, recent
evidence indicates that neurodegenerative disorders such as
Huntington’s disease (HD) display alterations early during
neurogenesis that may contribute to neurodegeneration later in
life [2–4]. Thus, methods to facilitate the understanding of
neurogenesis and the contribution of neurodevelopmental alter-
ations to neurodegenerative diseases are required.
In recent years, human embryonic stem cells (hESCs) and
human-induced pluripotent stem cells (hiPSCs), collectively
known as human pluripotent stem cells (hPSCs), have
emerged as versatile and powerful tools for research and ap-
plied medicine given their ability to differentiate into any cell
type of the human body including neurons [5]. Thus, hPSCs
provide a powerful tool to gain insight into the mechanisms
underlying human neurogenesis and enhance understanding
of how neurodevelopment is altered in neurodegenerative dis-
eases. Furthermore, hPSC-based therapies for the treatment of
neurodegenerative diseases are possible by the differentiation
of hPSCs to the affected neuronal type for subsequent trans-
plantation into patients.
Differentiating hPSCs to a specific neuronal type is a com-
plex endeavour that requires a robust effective in vitro differ-
entiation protocol that mimics in vivo neurodevelopment
through the addition of the necessary morphogens, growth
factors, small molecules and other components at the relevant
concentration and time [6–8]. In vitro neuronal differentiation
can be broadly divided into three main phases, namely neural
induction, neural progenitor patterning and terminal neuronal
differentiation and maturation.
Neural induction of hPSCs requires the inhibition of Wnt
and bone morphogenetic protein (BMP) signalling which
would otherwise drive the hPSCs to a non-neural fate [9].
Indeed, it was observed that the absence of BMP signalling
induces the expression of neural-specific factors [10].
Inhibition of the transforming growth factor beta (TGFβ)
and canonical Wnt pathways are also required for neural in-
duction as these pathways are implicated in maintaining
pluripotency [11, 12].
During neurodevelopment, neural progenitor cells (NPCs) are
patterned along the dorsoventral (DV) and anteroposterior (AP)
axes of the neural tube to generate the progenitors that will pro-
duce the numerous different neuronal types of the forebrain,
midbrain and hindbrain [1]. Following specification of a fore-
brain identity, gradients of TGFβ and BMP signalling specify a
dorsal NPC identity which gives rise to cortical neurons [13].
Conversely, Sonic hedgehog (SHH) signalling induces a ventral
identity which produces the ganglionic eminence NPCs that give
rise to striatal neurons among others [14, 15].
Following the differentiation of the patterned NPCs to neu-
rons, terminal neuronal differentiation and maturation are re-
quired for neuronal survival, plasticity and brain circuit integ-
rity and function. For neurons to correctly differentiate and
mature, they must progressively gain excitability, and acquire
passive and active neuronal properties able to generate and
transmit action potential [16]. Neuronal maturation depends
on the synergistic action of developmental transcription fac-
tors (TFs), the activation or inhibition of intracellular signal-
ling pathways, cell-to-cell interactions, and extracellular fac-
tors such as neurotransmitters (NTs), neurotrophic factors or
ionic concentrations [17].
The generation of functional mature neurons differentiated
from hPSCs is essential for the study of neuronal differentia-
tion and also neuronal activity at both the individual neuron
and network level. We have previously reported that the ap-
plication of a cocktail of soluble molecules to hPSC-derived
NPCs generates electrophysiologically active neurons that
display relative negative membrane potentials and elicit spon-
taneous trains of action potentials [18].
A successful neuronal differentiation protocol must be ro-
bust and generate a similar outcome with different hPSC lines.
Ideally, a neuronal differentiation protocol should generate
functionally mature neurons in a relatively short amount of
time to accelerate investigation. Furthermore, the differentia-
tion of the cells as they progress through the protocol must be
well-characterised at the gene expression level to demonstrate
that the protocol mirrors the gene expression dynamics that
occur in vivo. Also, the neurons that are generated should be
characterised at the functional level to demonstrate that their
activity is comparable with that of the equivalent in vivo neu-
rons. Finally, in addition to in vitro analyses, from a cell ther-
apy perspective, it must be possible to transplant the hPSC-
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derived NPCs into the relevant brain area where they should
survive, differentiate into neurons and integrate into the host
brain circuitry.
In this work, we provide a step-by-step characterisation
at the gene expression and functional levels of the differ-
entiation of hiPSC and hESC lines to functionally mature
ventral forebrain neurons, including striatal medium spiny
neurons, in a relatively short period of time. We observed
the production of patterned NPCs after 16 days in vitro
(DIV) which subsequently differentiated to spontaneously
active and synaptically mature neurons in a further 21 days
(37 DIV). Gene expression analysis using our high-
throughput quantitative PCR (qPCR) platform to assess
forebrain neuronal differentiation revealed gene expres-
sion dynamics similar to those observed during
neurodevelopment [19]. Spontaneous neuronal activity
was demonstrated using a single-cell calcium (Ca2+) im-
aging assay in combination with a novel semi-automatic
MATLAB-based software toolbox (NETCAL) that we de-
veloped previously [20]. We also transplanted hPSC-
derived NPCs into neonatal mouse striatum where they
differentiated to neurons, survived for a prolonged period,
projected axons to the relevant host brain target areas and
established synaptic connections.
Overall, we present a fast and robust method for the differ-
entiation of hPSC to neurons which will help advance the
study of human neurodevelopment, the treatment of neuronal
disorders, and will facilitate the design of high-throughput
drug screening and in vitro neurodevelopmental toxicology
procedures and stem cell-based therapies.
Material and Methods
Animals
B6CBA mice were obtained from Jackson Laboratory (Bar
Harbor, ME, USA). The animals were housed with access to
food and water ad libitum in a colony room kept at 19–22 °C
and 40–60% humidity, under a 12:12-h light/dark cycle.
Experiments were carried out according to the European regula-
tion (2010/63/UE) for the care and use of laboratory animals.
Human Stem Cell Lines
We compared the control (Ctr) Ctr-Q33, a hiPSC line, with 33
CAG repeats (generous gift from C. N. Svendsen, Cedar
Sinai, Los Angeles, CA; USA: CS83iCTR-33nxx) and
GENEA (GEN)-Q18, an ESC line, with 15/18 CAGs
(GENEA019; derived from GENEA Biocells; Australia;
hPSCreg Name: GENEAe020-A). All cells were regularly
tested for mycoplasma contamination and karyotype normal-
ity. Human cells are growth in a 37 °C incubator with a
humidified atmosphere and 5% CO2. G-band karyotypes
were made in an external centre, Ambar-Anàlisis Mèdicas
(Barcelona, Spain).
GEN-Q18 hESC Expansion
GEN-Q18 hESC was cultured in feeder-free matrigel coated
6-well plates in 2.5 ml of Genea M2 Medium (MED-02–
250 ml; 17G13CCMO23; Genea Biocells), a serum-free ful-
ly-defined medium containing bovine serum albumin (BSA),
bFGF, Activin A and growth factors. Medium was changed
every 2 days and daily in the 2 days before passaging due to
the higher cell confluency.
After a minimum of 4 passages in Genea M2 medium,
GEN-Q18 hESC was adapted and expanded in mTESR1 me-
dium as we describe below.
Human PSC Maintenance in mTeSR1 Media
All hPSCs were cultured on matrigel (354230; Corning Inc.,
NY, USA) feeder-free coated 6-well plates in 2 ml of serum-
free defined mTeSR1 medium which contains recombinant
human bFGF and recombinant human TGFβ (complete
mTeSR1: mTeSR1 basal medium (05850) and mTeSR1 sup-
plemented 5x (05852); StemCell Technologies Inc., MA,
USA). Medium was daily changes (every 24 h ± 2).
Human Pluripotent Stem Cells Passaging Protocol
with ROCK Inhibitor
HPSC cultures were passaged when cell confluence reached
70–80% (twice per week). Cells were gently washed twice
with 2 ml of Dulbecco’s (D)-phosphate-buffered saline
(PBS) without calcium and magnesium (D-PBS−/−, 14,190–
250; Thermo Fisher Scientific Inc., MA, USA) and incubated
for 20–25 min with dispase in DMEM/F12 (07923; Stem cell
Technologies, Cambridge, UK) with 10 μM of ROCK inhib-
itor (Y-27632; EVOTEC Ltd. Milton, UK) at 37 °C. Then,
dispase was removed and cells were harvested in
DMEM/F12 (Stem cell Technologies) media by pipetting up
and down using a 5-ml pipette to avoid single-cell desegrega-
tion. Cells were centrifuged at 1000 rpm for 3 min and resus-
pendedwith warm and fresh Complete-mTeSR1mediumwith
10 μm of ROCK inhibitor (Abcam Inc.) at the desired dilu-
tion. Then, cell suspension was seeded on tempered matrigel
coated 6-well plates. Differentiated colonies were removed
manually using a stereotypic microscope and a 10-ml sterile
tip prior passaging.
Human PSC Neuronal Differentiation Protocol
A schematic illustration of the differentiation protocol is
shown in Fig. 1. At 60–70% of cell confluence, hPSC cultures
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were washed 3 times with 2 ml of D-PBS with calcium and
magnesium (PBS+/+, 14040-091; Thermo Fisher Scientific
Inc., MA, USA). The medium was then replaced by neural
induction SLI medium from 0 DIV until 8 DIV (SLI culture
media: Advanced DMEM/F-12(1X) (12634-010; Thermo
Fisher Scientific Inc.) with 2 mM of GlutaMax™ 100x
(35050-038, Thermo Fisher Scientific Inc.), 1% penicillin/
streptomycin (P/S; 15140122; Thermo Fisher Scientific Inc.,
MA, USA); 10 μM SB 431542 (SB; 447536; EVOTEC Ltd.
Milton, UK.); 1 μM LDN 193189 (396388; EVOTEC Ltd.
Milton, UK); 1.5 μM IWR1 (476979; EVOTEC Ltd. Milton,
UK), and 2% B27-supplemented without RA (50X) (12587-
010; Thermo Fisher Scientific Inc.)).
At 4 DIV, confluent cultures were treated with 10 μM of
ROCK inhibitor (Abcam Inc.) for 1 h, washed twice with 2 ml
of PBS without calcium and magnesium (Thermo Fisher
Scientific Inc.), incubated with accutase (StemPro A11105;
Thermo Fisher Scientific Inc.) for 7 min for cell dissociation
and passaged onto matrigel-coated plates, with a split ratio of
1:2. On 8 DIV, cultures were passaged 1:2 and cultured in LI
medium until 15DIV (LI culture media: AdvancedDMEM/F-
12(1X) (Thermo Fisher Scientific Inc.) with 2 mM of
GlutaMax ™ 100x (Thermo Fisher Scientific Inc.), 1% P/S
(Thermo Fisher Scientific Inc.), 200 nM LDN 193189,
1.5 μM IWR1 and 2% B27-supplemented without RA
(50X) (Thermo Fisher Scientific Inc.)).
Cultures received daily medium changes of 2 ml except
from DIV 5 to DIV 7 (both included), when 4 ml of fresh
medium were added. At 16 DIV, NPCs were washed 3 times
in PBS−/− (Thermo Fisher Scientific Inc.), dissociated with
accutase for 5 min and plated with a population of 8 × 104
cells in 12-mm-diameter glass coverslips (treated and coated).
Prior to use, coverslips were cleaned with 70% nitric acid,
washed 5 times with deionized water and one time with abso-
lute ethanol (1009832500; CAS 64-17-5; MERCK Millipore,
Darmstadt, Germany) and oven sterilized at 180 °C o.n. CSs
were coated first with 100 μg/ml poly-D-lysine (P0899-
100 mg; Sigma-Aldrich) in borate buffer (15663; Fluka-
Sigma-Aldrich Chemie GmbH; Steinheim, Germany) and
with matrigel. Cells were differentiated for additional 21
DIVs in SCM1/2 media (SCM1 from 16 DIV until 23 DIV
and SCM2 from23DIVuntil 37DIV changed every 2–3 days)
(SCM1 culture media (changed at 16 DIV, 18 DIV and 21
DIV): Advanced DMEM/F-12 (1X) (Thermo Fisher
Scientific Inc.) with 2 mM of GlutaMax™ 100x (Thermo
Fisher Scientific Inc.); 1% P/S (Thermo Fisher Scientific
Inc.); 2% B27-supplemented (50X) (17504-044; Thermo
Fisher Scientific Inc.); 2 μM PD 0332991 (482855;
EVOTEC Ltd. Milton, UK); 10 μM DAPT (396736;
EVOTEC Ltd. Milton, UK); 0.6 mM CaCl2 (to give
1.8 mM final complete medium; MERCK, CAT, Spain),
200 μM ascorbic acid (AA; A4544-100G; Sigma-Aldrich,
Madrid, Spain), 10 ng/ml hBDNF (450-02; Peprotech Inc.,
NJ, USA); 10 μM Forskolin (FK,000087; EVOTEC Ltd.),
3 μM CHIR 99021 (CH; 401952; EVOTEC Ltd. Milton,
UK) and 300 μM GABA (0.44; Tocris Cookson Inc., MO,
USA)). (SCM2 culture media: (1:1) of Advanced DMEM/F-
12 (1X) (Thermo Fisher Scientific Inc.) with 2 mM of
GlutaMax™ 100x (Thermo Fisher Scientific Inc.):
Neurobasal A (10888-022; Thermo Fisher Scientific Inc.);
1% P/S (Thermo Fisher Scientific Inc.), 2% B27-
supplemented (50X) (Thermo Fisher Scientific Inc.); 2 μM
PD (EVOTEC Ltd.); 3 μM CH (EVOTEC Ltd.); 0.3 mM
CaCl2 (to give 1.8 mM final complete medium MERCK);
200 μMAA (Sigma) and 10 ng/ml hBDNF (Peprotech Inc.)).
NPC Transplantation in Neonatal Mouse Striatum
To track the cells after transplants, Ctr-Q33 hiPSC line was trans-
duced with green fluorescent protein (GFP) lentivirus under the
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control of the constitutive elongation factor alpha (EF1-α) pro-
moter during WiCell maintenance. Lentivirus was incubated for
2 h at 37 °C. Cultures were grown and maintained in WiCell
procedure until cell sorting by FACS (fluorescence-activated cell
sorting). After three passages, transfected cells were sorted by the
expression of GFP. Sorted cells were grown and maintained in
WiCell procedure and adapted and expanded to mTesR1 medi-
um after karyotyping test.
Ctr3-Q33-GFP NPCs at 16 DIV were harvested and resus-
pended in D-PBS−/− (Thermo Fisher Scientific Inc.). P (post-
natal day) 2 neonatal mice were anaesthetised by hypothermia
and placed on ice until cessation of movement. Unilateral
striatal injections were performed using a stereotaxic appara-
tus (Davis Kopf Instruments, Tujunga, CA, USA) and a 10-μl
Hamilton syringe with a 33-gauge needle (Hamilton, Reno,
NV), setting the following coordinates (millimetres): AP, +
2.3, L, + 1.4 from lambda and dorsoventral, − 1.8 from dura.
Every animal received 15,000 cells diluted in 1 μl of D-PBS−/
− (Thermo Fisher Scientific Inc.). Upon completion of stereo-
taxic surgery, pups were warmed, monitored for 1 h to ensure
recovery and then returned to the housing facility.
Immunocytochemistry
HPSC-derived cultures were fixed for 20 min at room temper-
ature (r.t.) with 200 μl/ 24-well of 4% paraformaldehyde so-
lution (P/0840/53; Fisher Scientific UK Limited,
Leicestershire, UK) and washed three times with 1x PBS
and stored at 4 °C in 500 μl/ 24-well with 0.03% sodium-
azide (71289; Fluka-Sigma-Aldrich) until use. For
immunolabelling, samples were blocked and permeabilized
for 45 min at r.t. with PTB solution (PBS 1x with 0.3%
Triton X-100 (T8532; Sigma-Aldrich Quimica SL., Madrid,
Spain), 0.03% sodium-azide, 1% BSA (A9647-1006; Sigma-
Aldrich, Madrid, Spain) and 5% normal goat serum (NGS;
S-1000; Vector Laboratories Ltd., UK) and/or 5% donkey
serum (NDS; 017-000-121; Jackson Immuno Research
Laboratories Inc.; PA, USA)), before being incubated over-
night (o.n.) at 4 °C with the appropriate primary antibodies
(Antibody references and dilutions are defined in Table 1).
After o.n. incubation, primary antibodies were removed, and
samples were washed 3 times for 10 min with PBS 1x upon
the tilt table. Then, cells were incubated for 1–2 h at RT in
darkness with fluorophore-conjugated secondary antibodies
(References and dilutions are detailed in Table 1). After three
washes of 10 min with PBS 1x, cells were counterstained with
nuclear staining with DAPI 300 nM (D1306; Thermo Fisher
Scientific). Coverslips were mounted in Fluoromount-G me-
dia (0100-01; Southern Biotech, AL, USA) and imaged using
an Olympus IX71 inverted microscope equipped with an Orca
Flash 4.0 camera (C11440-22CU, Hamamatsu Photonics
France sucursal España, Barcelona, Spain) or the Leica SP5
TCS two-photon laser scanning confocal microscope (Leica
Microsystems, Wetzlar, Germany).
Immunohistochemistry
Animals were deeply anaesthetised with pentobarbital
and intracardially perfused with PBS 1x and a 4% para-
formaldehyde solution (P/0840/53; Fisher Scientific UK
Limited, Leicestershire, UK) in 0.1 M sodium phosphate
(CAS 7601-54-9; Sigma-Aldrich, Madrid, Spain). Brains
were removed and post-fixed o.n. in the same solution,
washed three times with PBS 1x, cryoprotected with
30% sucrose (CAS 57-50-1; Sigma-Aldrich, Madrid,
Spain) in PBS 1x and frozen in dry-ice cooled
methylbutane (CAS 78-78-4; Sigma-Aldrich, Madrid,
Spain). Serial coronal sections (20 μm) of the brain
were obtained using a cryostat (Microm 560 M,
Thermo Fisher). Tissue was first incubated with a
blocking solution containing PBS 1x, 0.3% Triton
X-100 (Sigma-Aldrich Quimica SL.) and 5% normal
horse serum (31874; Thermo Scientific, IL, USA) for
2 h at RT. Brain sections were then incubated o.n. at
4 °C with different primary antibodies diluted in the
blocking solution (see Table 1). After three washes with
PBS 1x, tissue was incubated for 1 h and a half at RT
with specific fluorophore-conjugated secondary antibod-
ies. Images were acquired with a Leica SP5 TCS two-
photon laser scanning confocal microscope (Leica
Microsystems).
Immunogold Labelling and Transmission Electron
Microscopy
For transmission electron microscopy (TEM) studies,
samples were fixed with a solution of 2% PFA/0.5%
glutaraldehyde in 0.1-M phosphate buffer, post-fixed
with 1% osmium tetroxide, dehydrated and embedded
in epoxy resin. Semi-thin sections (1 μm) were stained
with methylene blue. Ultra-thin sections (70 nm) were
immunolabelled with primary antibody, followed by in-
cubation with a secondary antibody conjugated with
10 nm electron-dense colloidal gold (Aurion, Electron
Microscopy Sciences). GFP antibody (Abcam) was used
for detecting human cells. Images were acquired with a
JEOL 1010 transmission electron microscope equipped
with a CCD Orius camera (Gatan).
Unbiased Cell Counts
Neural Progenitor Cell Counts by CellProfiler Software
HPSC-derived NPC populations at 16 DIV were quantified
using an open-access CellProfiler software (BROAD institute,
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MA, USA). Nineteen random images, corresponding to 3% of
a 24-well plate (1.92 cm2) culture, were taken with the
epif luorescence Leica AF600 microscope (Leica
Microsystems). Images were loaded in a customized pipeline
with an initial nuclei detection by DAPI immunofluorescence
and then the second channel, green, and the third channel, red,
immunolabelled detected-nuclei counts.
Neuronal Cell-Type Counts by CAST Program
HPSC-derived neuronal cell types at 23 DIVand 37 DIV were
manually counted using a nonbiased computer-assisted ste-
reological toolbox (CAST) program (Olympus America Inc.,
NY, USA).We counted the 3% of a 12-mm-diameter coverslip
(1.2 cm2) culture area.
Table 1 List of primary and
secondary antibodies used in the
work
Primary antibodies
Target Supplier Reference Host Dilution Used
5-HT Sigma S5545 R * 1/5000 ICC **
ChAT Chemicon AB144P G * 1/100 ICC
CTIP2 (25B6) Abcam ab18465 Rat 1/300 ICC
DARPP-32 (H62) Santa Cruz Biotechnology Sc-11365 R 1/100 ICC
DARPP-32 (19A3) Cell signalling 2306 R 1/ 500 IHC **
DLX_ pan CHD1 PA5967 R 1/150 ICC
EBF_ pan CHD1 PA590 R 1/200 ICC
GABA Sigma A2052 R 1/500 ICC
GFP Abcam Ab6556 R 1/500 TEM
Human Nuclei (HNA) Millipore MAB4383 M * 1/100 IHC
MAP2b BD Transduction Laboratories 610460 M 1/500 ICC
MAP2(2a + 2b)(AP-20) Sigma M1406 M 1/500 IHC
Nestin Millipore MAB5326 M 1/200 ICC
OCT3–4 (C-10) Santa Cruz Biotechnology sc-5279 M 1/100 ICC
PAX6 Hybrido Bank Pax6 M 1/200 ICC
PLZO (2A9) Calbiochem OP128 M 1/100 ICC
PSD-95 Abcam Ab41455 R 1/150 ICC
SNAP25 Abcam Ab41455 R 1/150 ICC
Synaptophysin Synaptic Systems 101011 M 1/1000 ICC
TBR1 Abcam Ab31940 R 1/500 ICC
TH Abcam AB152 R 1/300 ICC
ZO-1 Invitrogen 40-2200 R 1/100 ICC
Β-III tubulin Sigma T220 R 1/500 ICC
SNAP25 (SMI 81) BioLegend 836306 M 1/1000 WB **
Syntaxin (HPC-1) Gift of Dr. C. Barnstable M 1/2000 WB
Synaptotagmin (41.1) Synaptic Systems 105011 M 1/1000 WB
Actin (C4) MP Biomedicals 0869100 M 1/20000 WB
Fluorophore-conjugated secondary antibodies
Target Supplier Reference Host Dilution Used
AF488 donkey α-M Jackson Immuno Research (JIR) 715-545-150 D * 1/500 ICC
AF488 donkey α-R JIR 711-545-152 D 1/500 ICC
Cy2 donkey α-G JIR 705-225-003 D 1/100 ICC
Cy3 donkey α-R JIR 711-165-152 D 1/500 ICC
Cy3 α-rat JIR 712-165-150 Rat 1/500 ICC
Phalloidin-TRITC Sigma P1951 – 1/500 ICC
GFP-FITC Abcam Ab6662 G 1/200 IHC
HRP-conjugated secondary antibodies
HRP α- M Dako P0161 1/5000 WB
*Host: M mouse; R rabbit; G goat; D donkey
**Used: ICC immunocytochemistry; IHC immunohistochemistry; WB western blot
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Graft Size and Neuronal Counts of Transplanted Cells
Graft size was calculated by delineating the outer perimeter of
GFP+ cells in eight transplanted mice. The volume occupied
by the graft core was estimated through extrapolation of the
area quantified in sections spaced 120 μm apart, by using an
Olympus optical microscope and CAST stereology software.
For determining the neuronal fate of transplanted cells, immu-
nofluorescence images were acquired with a TCS SP5 confo-
cal microscope (Leica) and manually counted using the
ImageJ and CAST software. Immunolabelled cells in the re-
gions of interest were quantified using high intensity projec-
tion of Z stacked images on five evenly-spaced coronal sec-
tions from six transplanted mice at each time point.
Calcium Imaging
Sixteen DIV NPCs seeded upon 12-mm-diameter glass cov-
erslips were differentiated into neurons and monitored for
their spontaneous dynamics at 37 DIV through multi-neuron
fluorescence calcium imaging. This technique enabled the si-
multaneous, large population tracking of neuronal firing by
the binding of Ca2+ ions to a fluorescent indicator.
Recordings were performed in artificial cerebrospinal fluid
solution (aCSF) (pH 7.4) composed by 128 mM NaCl,
4 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 45 mM sucrose,
10 mM glucose and 0.01 M HEPES. Fluo4-acetoxymethyl
ester (AM) (494/506 nm) (F14201; Thermo Fisher Scientific
Inc.) fluorescent Ca2+ sensitive indicator was used in all mea-
surements. Prior to imaging, cultures were placed in a 35-mm-
diameter glass bottom chamber (P35G-0-14-C, MatTek
Corporation, MA, USA) that contained 2 μM of Fluo4-AM
in a total volume of 2 ml of aCSF, and gently incubated on an
orbital shaker in darkness for 15min at RT. Cultures were then
washed twice with fresh aCSF and stabilized for 5 min at
37 °C with 4 ml of fresh aCSF. The recording chamber was
mounted on a Zeiss inverted microscope equipped with an
Orca Flash 2.8 CMOS camera (Hamamatsu Photonics) and a
light source for fluorescence. Image sequences of neuronal
activity were acquired for 10 min at RT, with a size of 960 ×
720 pixels, and a speed of 20 frames per second (FPS).
Microscope settings combined a × 5 objective with a × 0.63
optical zoom, providing a spatial resolution of 4.40 μm/pixel
and a field of view (FOV) of 4.2 × 3.2 mm2 that contained
3000–4000 cells. Representative bright field and fluorescence
images for a particular experiment are provided in Fig. S9.
Neuronal Activity Analysis
Ca2+ imaging recordings were analysed with NETCAL [20], a
custom-built software package run in MATLAB. For each
experiment, about 1000–3000 neurons (soma regions) were
automatically selected on the FOVof the culture based on the
brightness of the neuronal soma. Each soma denoted a region
of interest (ROI) spanning a square area 7 pixels wide (about
645 μm2). The fluorescence intensity of each ROI as a func-
tion of time, F*(t), was obtained by averaging the colour in-
tensity across all pixels within the ROI at every frame. To
reduce noise, fluorescence traces were smoothed out by ap-
plying a “moving average” filter 5 frames (250 ms) wide.
Traces were next corrected for small drifts by subtracting a
smoothed spline of the original signal. The spline was con-
structed by diving the original signal in blocks 25 s wide, and
by connecting in a spline manner the average value within
each block. The drift correction effectively removed large
time-scale fluctuations while preserving neuronal firing traits
and the original baseline fluorescence level (F0). Fluorescence
signals were finally normalized as F(t) = 100(F*−F0)/F0 ≡
ΔF/F0 (%). Examples of characteristic fluorescence traces
are provided in Fig. S9.
Neurons were separated in two groups (active or inactive)
based on their fluorescence profiles by means of supervised
machine learning algorithms. Briefly, several features of the
fluorescence traces were first extracted by identifying their
intervals of high activity. These intervals were set as the time
spanned by the signal above a given threshold. Next, about
100 representative traces for each group were manually select-
ed, and the rest were automatically assigned to the correspond-
ing group through a boosting algorithm [21]. Finally, for each
active neuron, spike trains were inferred through the “peeling
algorithm” [22, 23]. For single-spike detection, we used a
single-exponential model with a detection threshold of 0.8%
ΔF/F0 and a decay time constant of tau = 1 s.
To describe the activity properties of neurons, we defined a
set of nine neuronal activity features detailed in Fig. S10.
These features include number of spikes (NS); firing rate
(FR, spikes along time, Hz); inter-spike interval (ISI, s); stan-
dard deviation (SD) of ISI (s); number of bursts (B; defined as
concatenated spikes with intervals smaller than 1 s); number
of spikes within a burst; ISI inside a burst; inter-burst interval
(IBI, s); and burst length (s).
Data Segregation by PCA and K-Means Methods—NETCAL
The nine neuronal features obtained from the activity analysis
were transformed into a new basis by principal component
analysis (PCA) [24]. The PCA data was then split into 8 sig-
nificant groups through a k-means clustering algorithm [25].
The compound set of features of each of the groups was then
further analysed.
RNA Isolation and Retrotranscription
Total RNA was isolated along the neuronal differentiation
using TRI Reagent (TR118; Molecular Research Center;
Ohio, USA) following the manufacturers’ protocol. Ten
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microliters of total RNA at a concentration of 100–200 ng/μl
(1 μg in total) for each sample were reverse-transcribed with
random primers using the high-capacity RNA-to-cDNA Kit
(4387406, Thermo Fisher Scientific). Ten microliters of retro-
transcription cocktail (2μl of 10× retrotranscription (RT) buff-
er, 2 μl of Random primers, 1 μl of dNTP mix; 1 μl
MultiScribe reverse transcriptase) were added to each sample
(20 μl total volume). After gentle mixing, the samples were
incubated for 10 min at room temperature followed by 2 h at
37 °C, 10 min on ice and 10 min at 75 °C.
High-Throughput Quantitative PCR-Openarray
and Data Analysis
Open array analysis was performed as described elsewhere
[19]. Complementary cDNAs from 0 DIV to 37 DIV hPSC-
samples were loaded onto the custom openarrays and run as
recommended by the manufacturer on the QuantStudio 12 K
Flex Real-Time PCR system (Thermo Fisher Scientific) by
Servei Veterinari de Genètica Molecular (Faculty of
Veterinary, Universitat Autònoma de Barcelona, Cerdanyola
del Vallès, Spain). We ran two openarrays, the so-called de-
velopmental openarray with 112 TaqMan probes (Thermo
Fisher Scientific), and a second openarray called Ephys with
168 TaqMan probes [19]. Both openarrays specifically detect-
ed all isoforms of each gene that were selected from the liter-
ature, and included 6 housekeeping genes for the developmen-
tal (18S, B2M, HPRT1, HSP90AB1, RPL13A, UBC) and 10
housekeeping genes for the Ephys (18S, B2M, HPRT1,
HSP90AB1, RPL13A, UBC, PAPOLA, ACTB, EIF2B1,
TBP) that were used as reference genes. For data analysis,
Ctr-Q33 and GEN-Q18 samples were ran and analysed sepa-
rately. For each openarray, we took one random sample from
37 DIV as reference sample. Relative gene expression was
calculated using the Expression Suite Software 1.03 (Life
Technology, Barcelona, Spain). Relative quantity (RQ) mini-
mum and maximum values (error bars) were calculated with a
confidential level of 95%, using Benjamini-Hochberg false
discovery rate to adjust P values. Maximum allowed threshold
cycle Ct included in calculations is 30 and a quantitation cycle
Cq confidence > 0.8. Error bars are presented in all graphs as
standard error of the mean (SEM). Gene expression profile
data are represented in graphics as RQ to 37 DIV.
Protein Isolation and Western Blot
Total protein extract was isolated from human tissue using
TRI Reagent (T9424, Sigma-Aldrich, Madrid, Spain) accord-
ing to the manufacturer’s protocol. Total protein extracts were
denatured using 1% SDS at 100 °C for 5 min. Sixteen micro-
gram of each denatured sample was subjected to 12% SDS-
PAGE and transferred to a nitrocellulose membrane
(IPVH00010, Millipore, Barcelona, Spain) for 60 min at
1 mA/cm2. Membranes were incubated o.n. with primary an-
tibodies (Ref. and dilution defined in Table 1) in immunoblot
buffer (TBS-T-5%M; Tris-buffered saline (TBS) containing
0.05% Tween-20 and 5% no-fat dry milk) at + 4 °C in agita-
tion and 1 h at RT upon a tilt table with HRP secondary
antibodies in TBS-T-5%M. For load control, anti-alpha actin
(1:20,000) was incubated for 20 min at RT in TBS-T-5%.
Membrane development was performed in TBS-T-5% BSA.
Membranes were developed using the Luminata Classico or
Forte Western HRP Substrate (WBLUC0100 and
WBLUF0100, respectively, MERCK Millipore, Darmstadt,
Germany) in Fuji Medical X-Ray Films (Super RX-N;
Fujifilm Co., Tokyo, Japan).
Statistical Analysis
For comparisons between 16 DIV Ctr-Q33 and GEN-Q18
NPCs, two-way ANOVA followed by Tukey’s multiple com-
parison test was applied and values of P < 0.05 were consid-
ered statistically significant, *P < 0.05, **P < 0.005, ***P <
0.0005. Neuronal progenitor cells were represented as relative
to total labelled nuclei or relative to PAX6 NPCs in double
labelling. Error bars were presented in all graphs as standard
error of the mean (SEM).
For comparisons between Ctr-Q33 and GEN-Q18 neuronal
cell types at 23 DIVand 37 DIV, two-way ANOVA followed
by Tukey’s multiple comparison test was applied, *P < 0.05,
**P < 0.005, ***P < 0.0005. Neuronal cell types were repre-
sented as relative to total labelled nuclei by DAPI immuno-
fluorescence or relative to Map 2b. Error bars were presented
in all graphs as SEM.
For gene expression comparisons along the differentiation
from 0 DIV to 37 DIV, one-way ANOVA followed by
Tukey’s multiple comparison test was applied. Relative to 0
DIV, *P < 0.05, **P < 0.01, ***P < 0.001; to DIV 8 + P <
0.05, ++ P < 0.01, +++ P < 0.001; 12 DIV # P < 0.05, ## P <
0.01, ### P < 0.001; to DIV 16 $$ P < 0.01, $$$ P < 0.001; to
23 DIV & P < 0.05, && P < 0.01 and &&& P < 0.001. Error
bars were presented in all graphs as SEM. Gene expression
profile data were represented in graphics as RQ to 37 DIV.
For firing and bursting feature comparisons between
groups, G1 to G8 at 37 DIV, one-way ANOVA followed by
Tukey’s multiple comparison test was applied.P < 0.05 *,P ≤
0.01 ** and P ≤ 0.001 ***. P > 0.05. Data is summarized in
Fig. S12 and grey boxes).
Colour matrices represented all possible comparisons on
the diagonal (blue box; 0 DIV to 37 DIV) on which the sta-
tistical test was carried out for all the multiple comparisons.
Non-expressing genes were indicated with grey boxes. Colour
boxes for expressing genes with P < 0.05. Upregulated (red)
and downregulated (green) genes were represented with in-
creasing three colour-scale intensities for P ≤ 0.5, P ≤ 0.005
and P ≤ 0.0005, respectively.
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Protein quantification of Ctr-Q33 and GEN-Q18 at DIV 0,
DIV 23 and DIV 37 was calculated by relative quantity to alpha-
actin band. One-way ANOVA followed by Tukey’s multiple
comparison test was applied and values of P < 0.05 were con-
sidered statistically significant. Relative to 0 DIV, *P < 0.05,
**P < 0.005, ***P < 0.0005; to DIV 23 # P < 0.05, ## + P <
0.01, ### P < 0.001. Protein levels were represented in graphics
as relative protein to alpha-actin and error bars as SEM.
Quality System
All procedures were conducted under UNE-EN-
ISO9001:2015 and comply with the Guidance Document on
Good In Vitro Method Practices (GIVIMP; OECD) recom-
mendations [26].
Results
Two sources of hPSC cell lines, an induced Ctr-Q33 and an
embryonic GEN-Q18 hPSCs, successfully differentiated into
forebrain mature neurons in 37 DIV. The in vitro neuronal dif-
ferentiation comprised 3 successive stages illustrated in Fig. 1.
First, the protocol consisted in the neural induction and expan-
sion of progenitor cells during the first 8 DIV. Second,
neuroectodermal (NE) progenitors were regionalized into anteri-
or forebrain or telencephalic NPCs at 16 DIV. And, third, the
protocol promoted hPSC-derived NPCs cell cycle exit together
with terminal neurogenesis and synaptogenesis until 37 DIV.
All gene and protein nomenclatures are detailed in
Table S1.
The Synergetic Dual-SMAD and WNT Inhibition Forces
hPSCs to Exit from Pluripotency
At 0 DIV, both hPSC cell lines are arranged in monolayer
colonies throughout the culture. HPSC colonies were entirely
composed by pluripotent cells positive for OCT-3/4 TF (Fig.
S1a and b and panels a’ and b’). HPSCs began to differentiate
by using dual-SMAD inhibition along with Wnt/β-catenin
inhibitor (SLI media; neural induction Fig. 1). By means of
quantitative gene expression analysis, we observed that both
hPSC cell lines downregulated the expression of well-known
pluripotent TFs POU5F1 (OCT4), NANOG and KRT18 (Fig.
S1 panels c and d).
HPSC-Derived Neuroepithelial Progenitors
Homogeneously Neuralize in Bi-dimensional Neural
Tube-like Structures After 8 DIV
For neural fate specification and neurulation of hPSC, fourth
additional days of BMP, TGFβ and Wnt/β-catenin inhibitors
were applied to hPSC-derived cultures from 4 DIV to 8 DIV
(Fig. 1; neural induction). HPSCs successfully acquired a
neuroepithelial (NE) progenitor identity at 8 DIV. These NE
progenitors are self-arranged in bi-dimensional neural tube-like
or rosette structures (Fig. 2). Moreover, hPSC-derived NE pro-
genitors expressed neurulation proteins ZO1, tight junction pro-
tein 1 (TJP1) and PLZF (promyelocytic leukaemia zinc finger) at
protein and mRNA levels. Representative images of Ctr-Q33
and GEN-Q18 hPSC-derived NE cultures are shown in Fig. 2a
and Fig. 1b, respectively. As expected, PLZF is expressed within
the nucleus of NE progenitors (Fig. 2a and b), and ZO1 is
expressed apically at the luminal zone of the rosettes (Fig. 2a
and b). The acquisition of neural fate by hPSC-derived NE pro-
genitors was also corroborated by gene expression profile (Fig.
2c and d). The Zing finger and BTB domain containing 16
(ZBTB16/ PLZF) gene were induced at 8 DIV by Ctr-Q33 and
GEN-Q18 NE progenitors. In contrast, TJP1/ ZO1 was found
throughout the neuronal differentiation but its expression was
downregulated at late differentiation stages.
Additionally, Ctr-Q33 and GEN-Q18 hPSC-derived NE
cultures induced the expression of early NPC-related genes
(Fig. 3a and b, respectively). HPSC-derived NE progenitors
upregulated the cytoskeleton early neural gene nestin (NES)
from 8 DIV until 16 DIV. OTX-1, -2 and SOX2 genes were
upregulated from 8 DIV and became downregulated at late
differentiation stages (37 DIV). Neural identity of Ctr-Q33
and GEN-Q18 hPSC-derived cultures was corroborated by
immunolabelling for NES and β-III tubulin. At 12 DIV, Ctr-
Q33 cultures were mainly composed by nestin-positive NPC
along with few progenitors positive for the neuronal marker
β-III tubulin (Fig. 3c).
Regionalization of hPSC-Derived NPCs Gives Rise
to Mainly Subpallial Telencephalic Progenitor at 16
DIV
We next assessed by quantitative gene expression analysis the
regionalization of hPSC-derived NPCs. Figure S2 shows the
consolidation of the anterior commitment of Ctr-Q33 and
GEN-Q18 hPSC-derived NPCs (S2a and b, respectively).
Both cell lines induced the expression of the forebrain
FOXG1, DACH, SIX3 and GLI3genes at 16 DIV. We neither
detected expression of the midbrain PAX2, hindbrain HOXB
4/9 nor the spinal cord FOXA2A region-specific genes along
the neuronal differentiation (data not shown). From 8 DIV to
16 DIV, Ctr-Q33 and GEN-Q18 cultures progressed towards
the neuronal differentiation by expressing the neuronal genes
DCX, TUBB3 and NCAM1 (doublecortin, β-III tubulin and
neural cell adhesion molecule respectively; Fig. S3).
In order to distinguish among the different NPC subtypes,
we quantified the proportions of dorsal PAX6+ NPCs and
ventral DLX_pan+ and early B cell factor 1 (EBF1)+ NPCs
present at 16 DIV (Fig. 4a). Ctr-Q33 and GEN-Q18 cultures
contained similar proportions of ventral DLX+ and EBF1+
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NPCs (Fig. 4b). For DLX_pan NPCs, Ctr-Q33-derived cul-
tures contained 42 ± 2% and GEN-Q18-derived cultures 39 ±
3%. For EBF1, the proportions were slightly lower compared
with DLX_pan in both cell lines, 24 ± 1% and 26 ± 1% for
Ctr-Q33 and GEN-Q18, respectively. For dorsal progenitors,
GEN-Q18 cultures contained more PAX6+ NPCs compared
with Ctr-Q33 cultures at 16 DIV with 45 ± 2% and 26 ± 2%,
respectively (Fig. 4b). However, since PAX6 besides specify
dorsal NPCs is also expressed by NE progenitors [27], we
discriminated between PAX6+ early NE progenitors and
pallial-specific PAX6+ NPCs. To do so, we performed double
labelling of dorsal and ventral markers (Fig. 4d and e). From
the entire PAX6 population, most PAX6+ NPCs co-labelled
with ventral markers. In Ctr-Q33-derived NPC cultures, 47%
± 3 PAX6 progenitors co-labelled with DLX_pan and 41 ± 5%
with EBF1 (Fig. 4c). In GEN-Q18-derived NPC cultures, 28
± 2% of PAX6 progenitors co-labelled with DLX_pan and 36
± 1.3% with EBF1 (Fig. 4c). Representative images from the
double-labelled dorsal and ventral NPCs in Ctr-Q33 and
GEN-Q18 at DIV 16 are illustrated in Fig. 4d and e,
respectively.
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Fig. 3 Quantitative gene expression of neural NES, OTX-2/1 and SOX2
genes by a Ctr-Q33 and b GEN-Q18 hPSC-derived cultures along the
neuronal differentiation. (Mean ± SEM; one-way ANOVA followed by
Tukey’s multiple comparison test, relative to 0 DIV *P < 0.05, **P <
0.01, ***P < 0.001; to 8 DIV + P < 0.05, ++ P < 0.01, +++ P < 0.001; to
16 DIV $$ P < 0.01, $$$ P < 0.001). c Immunofluorescence for the early
NPCmarker nestin (red) and the neuronal progenitor markerβ-III tubulin
(green) in Ctr-Q33 hiPSC-derived NPC cultures at DIV 12. Scale bar
50 μm
 Fig. 2 Immunostaining of neural tube-like markers, PLZF (green) and
ZO1 (red) in aCtr-Q33 and bGEN-Q18 hPSC-derived NE progenitors at
DIV 8. The squared boxes (a‘and b‘) show a magnified field of view
(FOV) from a and b. Scale bar 50 μm. Quantitative gene expression of
ZBTB16/PLZF and TJP1/ZO1 along c Ctr-Q33 and d GEN-Q18
neuronal differentiation. (Mean ± SEM; one-way ANOVA followed by
Tukey’s multiple comparison test, relative to 0 DIV *P < 0.05, **P <
0.01, ***P < 0.001; to 8 + DIV P < 0.05, ++ P < 0.01, +++ P < 0.001; to
16 DIV $$ P < 0.01, $$$ P < 0.001)
2776 Mol Neurobiol (2020) 57:2766–2798
Furthermore, we analysed the most relevant TFs involved
in telencephalic specification. The differentiation of hPSC re-
sembled endogenous striatal neural differentiation. From 12
DIV to 16 DIV, cells upregulated the expression of LGE VZ-
related GSX2 and GSX1 genes which were afterwards down-
regulated from 23 DIV onwards (Fig. 5a). The LGE VZ-
related ASCL1 gene displayed a single-induction peak at 16
DIV and thereafter, it became downregulated from 23 DIV
onwards (Fig. 5a and S4a, for Ctr-Q33 and GEN-Q18, respec-
tively). Interestingly, differentiated hPSC displayed a gradual
expression of DLX genes from 16 DIV onwards (Fig. 5b).
HPSC-derived NPCs induced the expression of the SVZ-
related DLX2 and DLX1 at 16 DIV (Fig. 5b and S4b) follow-
ed by the induction of the striatal MZ-related DLX5 and
DLX6 genes along with EBF1 from 23 DIV (Fig. 5c and
S4c). As expected, the expression of PAX6 was found early
from 8 DIV, to specify neural fate, to 16 DIV (Fig. 5d and
S4d). Thereafter, the cortical SVZ-related EOMES displayed
a single-induction peak at 12 DIVand became downregulated
afterwards until the end of the differentiation. Finally, hPSC-
derived cultures upregulated the cortical plate (CP)-related
TBR1 gene at 16 DIV (Fig. 5f and S4f).
HPSC-Derived Neurons Reached Synaptic Maturity
at 23 DIV
HPSC-derived NPCs differentiated and generated postmitotic
neuronal cultures (Fig. 6). Quantitative gene expression of
mature neuronal genes MAP2 and RBFOX3 (NeuN) were
induced by both hPSC cell lines starting at 16 DIV (Fig. 6a
and b). Ctr-Q33 and GEN-Q18 cell lines gave rise to almost
100% of Map2b neurons from 23 DIVonwards, without dif-
ferences between cell lines at 23 DIV and 37 DIV (for Ctr-
Q33, 97% and 95%, and for GEN-Q18, 99% and 98% at 23
DIV and 37 DIV, respectively; Fig. 6c). Consistently, we ob-
served that hPSC-derived neurons displayed neurites out-
growth and abundant arborisations as differentiation
progressed (Fig. 6d and e).
To confirm whether hPSC-derived neurons achieved syn-
aptic maturation after neuronal differentiation, we analysed
the expression of synaptic-related markers at protein (Fig. 7)
and their gene expression levels (Fig. 8). HPSC-derived neu-
rons expressed the soluble NSF attachment protein (SNA)
REceptor (SNARE) proteins synaptotagmin, syntaxin-1 and
synaptosomal-associated protein 25 (SNAP-25) at 23 DIVand
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37 DIV. All three SNAREs were largely expressed at 37 DIV
compared with 23 DIV (Fig. 7a and b). SNAP25 was also de-
tected by immunofluorescence along with the postsynaptic
NMDAR subunit 1 (NR1) at 37 DIV (Fig. 7c). Ctr-Q33-
derived neurons displayed abundant punctate SNAP-25 staining
throughout the cytosol and projections of which some SNAP-25
punctuates co-localized with NR1, as shown in Fig. 7d.
We next performed a wide screening of a set of presynaptic
and postsynaptic genes along the Ctr-Q33 hiPSC neuronal
differentiation (Fig. 8). Ctr-Q33-derived neurons upregulated
the expression of presynaptic endocytosis-related protein
BIN1 from DIV 16. Synaptotagmin V (SYT5), synapsin I
(SYN1), vesicle-associated membrane protein 2 (VAMP2)
and synaptic vesicle glycoprotein 2C (SV2C) genes were
found induced from 23 DIVonwards (Fig. 8a). At 37 DIV,
Ctr-Q33 neurons induced the gene expression of SNAP-
25 and synaptophysin (SYP). Conversely, the neuronal
differentiation resulted in the downregulation of SYT2,
VAMP5 and SYNJ2 (Fig. 8a). Regarding postsynaptic
genes, Ctr-Q33 neurons showed a significant upregulation
DLG2 (PSD-93; Discs large homologues 2/postsynaptic
density protein 93) at 37 DIV (Fig. 8b). Other postsynap-
tic proteins, such as DLG1/SAP97, DLG3/SAP102 and
DLG4//PSD95, were expressed along Ctr-Q33 hiPSC dif-
ferentiation but they did not show significant differences
between DIVs (Fig. S17a).
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(Mean ± SEM; one-way ANOVA followed by Tukey’s multiple
comparison test, relative to 0 DIV *P < 0.05, **P < 0.01, ***P <
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Neuronal Cultures Comprise GABA, TH
and TBR1-Expressing Neurons from 23 DIV
We performed a detailed characterization of the main fore-
brain neuronal cell types, including GABAergic, glutamater-
gic, dopaminergic (DAergic) -tyrosine hydroxylase (TH)+
neurons and MSN-like neurons, in Ctr-Q33 and GEN-Q18
hPSC-derived neuronal cultures.
Ctr-Q33 and GEN-Q18-derived neuronal cultures
contained a high amount of GABA+/Map2b+ neurons at 23
DIV and 37 DIV (Fig. 9; Tables 2 and 3). Ctr-Q33-derived
neuronal cultures showed a tendency to decrease the number
of GABA+ population from 50 ± 8% at 23 DIV to 30 ± 6% at
37 DIV, whereas GEN-Q18-derived neuronal cultures showed
a slight increase from 38 ± 7% at 23DIV to 47 ± 7% at 37DIV
(Fig. 9a). Representative immunofluorescence images for
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these time points are shown in Fig. 9b for Ctr-Q33 and
Fig. S5 for GEN-Q18, highlighting the increase of
GABA+ projections, both in number and length, from
23 DIV to 37 DIV. GABAergic neuronal differentiation
was also corroborated by quantitative analysis of the
expression of a set of GABAergic-related genes (Fig.
9c for Ctr-Q33 and Fig. 9d for GEN-Q18). The cultures
had already upregulated the expression of GAD2,
CALB2 (calretinin) and SST (somatostatin) and the
interneuron-specific LHX1 (LIM homeobox 1) gene at
16 DIV.
Concerning DAergic-TH+ neurons, GEN-Q18 cultures at
23 DIV contained 50 ± 2% TH+/Map2b+ neurons, a much
higher population than the 19 ± 2% of Ctr-Q33 cultures
(Fig. 10a). As maturation progressed, however, the proportion
of TH+ neurons among lines reached similar values, with 36 ±
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Fig. 7 Expression of SNARE proteins by a CTR-Q33 and b GEN-Q18
from 23 DIVonwards. Relative quantity to alpha-actin. (Unpaired t test
with Welch’s correction, relative to 23 DIV *P < 0.05, **P < 0.005 and
***P < 0.001; Mean ± SEM). c Staining of SNAP-25 (red) and NR1
(green) in Ctr-Q33 hiPSC-derived neurons at DIV 37 with the
colocalization punctate in the magnified FOV b’1 and 2. White
arrowhead indicates NR1-SNAP-25 colocalization punctate; red
arrowhead single indicates SNAP-25 punctate. Scale bar 10 μm
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5% for Ctr-Q33 and 52 ± 4% for GEN-Q18 at 37 DIV
(Fig. 10a; Tables 2 and 3). Representative immunofluores-
cence images for TH and MAP2b at DIV 23 and 37 DIV are
shown in Fig. 10b for Ctr-Q33 and in Fig. S6a for GEN-Q18.
In both cases, the length of TH+ projections substantially in-
creased from 23 DIV to 37 DIV. These data were corroborated
by the induction of DAergic-related genes, NR4A2 (nuclear
receptor subfamily 4 group A member 2), TH and LMX1B
(LIM homeobox transcription factor 1 beta) from 16 DIV
onwards (Fig. 10e–g for Ctr-Q33 and Fig. 10h and i for
GEN-Q18). Many of the TH+ neurons were also found to
express GABA (Fig. S7), suggesting that a substantial propor-
tion of TH+ neurons is striatal interneurons which increase TH
expression as neuronal differentiation proceeds.
We also observed that hPSC-derived neuronal cultures
contained a low proportion of TBR1+ neurons. Both cell lines
exhibited less than 7% of TBR1+ neurons in the entire Map2b
+ population (Fig. 10c; Tables 2 and 3). Ctr-Q33 hiPSC-de-
rived neuronal cultures contained 4.0 ± 0.3% of TBR1+ neu-
rons at 23 DIV, which increased to 7.0 ± 0.4% at 37 DIV. In
GEN-Q18 cultures, the TBR1+ neuronal population tended to
decrease from 7 ± 3% at 23 DIV to 4 ± 1% at 37 DIV
(Fig. 10c). Representative images for nuclear TBR1 staining
along with Map2b at 23 DIV and 37 DIV are shown in
Fig. 10d for Ctr-Q33 and in Fig. S8b for GEN-Q18. Gene
expression analysis in Ctr-Q33 and GEN-Q18 cultures
showed an upregulation of the glutamatergic, TBR1 at 16
DIV, shown previously in Fig. 5 and Fig. S4. Additionally,
differentiated hPSCs upregulated the sodium-dependent inor-
ganic phosphate cotransporter, SLC17A6 or VGLUT1 gene
from 16 DIVonwards (Fig. 10j and k, for Ctr-Q33 and GEN-
Q18, respectively).
Striatal Projection Neurons Are Primarily Observed
at 37 DIV
We specifically checked the generation of GABAergic MSNs
by immunolabelling for CTIP2 (25B6) and DARPP-32
(Fig. 11 and Tables 2 and 3). Ctr-Q33 and GEN-Q18 neuronal
cultures clearly exhibited DARPP-32+/Map2b+ neurons at 37
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Fig. 8 Quantitative gene expression of presynaptic and postsynaptic
genes along Ctr-Q33 hiPSC neuronal differentiation. Matrices (DIV vs.
DIV) for a presynaptic and b postsynaptic genes along Ctr-Q33 hiPSC
neuronal differentiation. One-wayANOVA followed by Tukey’s multiple
comparison test was performed between DIVs (0 to 37). Coloured
matrices represent all possible comparisons on the diagonal (blue box;
DIVon which the statistical test is done for all the multiple comparisons);
non-expressing genes (grey boxes). Colour boxes for expressing genes
with P < 0.05. Upregulated (red) and downregulated (green) genes are
represented with increasing three colour-scale intensities for P ≤ 0.5, P ≤
0.005 and P ≤ 0.0005 respectively
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DIV, and without strong differences among cell lines (6.0 ±
0.3% and 4.0 ± 1.4%, respectively; Fig. 11a). Conversely, the
differentiation of hPSC generated abundant CTIP2 (25B6)+/
Map2b+ neurons at 23 and 37 DIVs. Ctr-Q33 cultures
contained 62 ± 12% and 55 ± 10% of CTIP2+ cells at 23
DIV and 37 DIV, respectively (Fig. 11c). GEN-Q18 neuronal
cultures contained 55 ± 14% at 23 DIV and 43 ± 3% of
CTIP2+ cells at 37 DIV (Fig. 11b). Both cell lines contained
equivalent proportions of double-labelled DARPP-32+ and
CTIP2+ neurons (Fig. 11c). Representative staining at both
DIVs in Ctr-Q33 hiPSC-derived neuronal cultures are shown
in Fig. 11d and e and Fig. S8a and b in GEN-Q18.
Quantitative expression of striatal-related neuronal genes
was observed along the neuronal differentiation (Fig. 12).
Confirming previous results from our group [19, 28], two
well-known MSNs markers, PPP1R1B/DARPP-32 and
CALB1, were expressed throughout the differentiation with
high levels at DIV 0 and DIV 37 (Fig. 12a–d). Conversely,
ZNF503 (zinc finger protein 503) and BCL11B/CTIP2 genes
were induced from DIV 16 onwards (Fig. 11e–h). The
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Fig. 9 Ctr-Q33 and GEN-Q18 hPSC-derived GABA+ neurons.
Proportion of GABA+ cells relative to MAP2b + in Ctr-Q33 (black)
and GEN-Q18 (grey) at 23 and 37 DIV (Mean ± SEM; two-way
ANOVA followed by Tukey’s multiple comparison test, ns P > 0.05). b
Representative GABA (green) staining along with the neuronal MAP2b
(red) and DAPI (blue) at both DIVs by Ctr-Q33 hiPSC-derived neuronal
cultures. Triangular arrowheads point intense GABA+ neurons and spiky
arrowheads highlight low GABA+ neurons. Scale bar 30 μm.
Quantitative GABAergic-related gene expression profile along c Ctr-
Q33 and d GEN-Q18 neuronal differentiation. (Mean ± SEM; one-way
ANOVA followed by Tukey’s multiple comparison test, relative to 0 DIV
*P < 0.05, **P < 0.01, ***P < 0.001; to 8 DIV + P < 0.05, ++ P < 0.01,
+++ P < 0.001; to 16 DIV $ P < 0.05, $$ P < 0.01, $$$ P < 0.001)
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neuronal differentiation promoted the expression of
ADORA2A and the TAC1 (tachykinin precursor) receptors
at 37 DIV (Fig. 11i–l). Other striatal-related genes, PENK
(ENK), OPRM1 (μ-opioid receptor), DR1 and DR2 receptors,
were detected at 37 DIV (Fig. 12m–t).
Three Large Patterns of Spontaneous Neuronal
Activity Are Displayed by Ctr-Q33 hiPSC-Derived
Neurons at 37 DIV
To assess whether the physiological maturation of the cultures
promoted neuronal activity, we carried out a single-cell, calci-
um fluorescence imaging assay at 37 DIV (Fig. S9). Since
sharp increases in the fluorescence calcium signal are associ-
ated with the generation of action potentials, we could exam-
ine the capacity of the hiPSC-derived neuronal cultures to
spontaneously fire. We observed that both Ctr-Q33 and
GEN-Q18 cultures showed spontaneous activity. For sake of
clarity, however, here we show the detailed analysis of the
data for the Ctr-Q33 line only.
As a first general observation, the analysis revealed a
high proportion of spontaneously active regions of interests
(ROIs), by 84%. Since the neuronal cultures contained
mostly pure Map2b+ at 37 DIV, ROIs were ascribed as neu-
ronal somas (Fig. S9a-c). The activity profiles across neu-
rons were asynchronous and heterogeneous (Fig. S9d), al-
though most of the neurons exhibited bursting events, i.e.
large amplitude firings that correspond to concatenated
action potentials. To characterize the patterns of activity
displayed by hPSC-derived neurons at DIV 37, we extracted
a set of neuronal features through a customized software
(NETCAL) run in MATLAB. We defined the number of
spikes (NS), the inter-spike interval (ISI), the number of
bursts (B), the inter-burst interval (IBI), spikes inside burst,
ISI inside burst and burst length (Fig. S10).
About 12,000 hPSC-derived neurons were analysed.
The different patterns of spontaneous activity were segre-
gated by analysing the set of neuronal features through
PCA and k-means algorithms (Fig. 13a). Each of the neu-
ronal features displayed different relative contributions to
the PCA axes (termed PC1 and PC2) as shown in Fig.
S10. As a central result of the classification, PC1 mostly
conveyed the IBIs feature, with a relative contribution of
84%, while the PC2 mostly conveyed he NS feature, with
a relative contribution of 79% (Fig. 13a). Thus, neurons
close to the PC1 axis and distant from the origin (0,0)
effectively exhibited high IBI values and low NS. This
characteristic ensemble of neurons was classified as
“low firing neurons” (Fig. 13a). Conversely, neurons near
and above the PC2 axis (Fig. 13a) elicited abundant
spikes but portrayed low IBI and were classified as “high
firing neurons”. In between these phenotypes, there
existed a group of neurons clustered at the centre of the
PCA plot and that was classified as “intermediate firing
neurons” (Fig. 13a). Illustrative neuronal traces for the
different classifications are shown in Fig. 13b.
Table 3 Neuronal subtype cell counts in GEN-Q18 hESC-derived neuronal cultures at 23 and 37 DIV
GEN Q18 DARPP-32 DARPP-32/Map2b Ctip2 (25B6) DARPP-32/Ctip2 Map2b GABA/Map2b TH/Map2b TBR1/Map2b
DIV 23 37 23 37 23 37 23 37 23 37 23 37 23 37 23 37
Diff 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
CSs 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Mean 0.4 4.2 0.1 4.0 55.0 42.7 0.4 4.0 98.7 98.3 37.7 46.6 49.7 51.7 7.4 4.2
SD 0.8 2.6 0.2 2.4 24.0 6.0 0.8 2.4 0.2 0.7 12.1 12.4 2.0 7.6 5.9 1.8
SEM 0.4 1.5 0.1 1.4 13.9 3.5 0.4 1.4 0.2 0.5 7.0 7.2 1.2 4.4 3.4 1.0
P value 0.1169 0.1233 0.5298 0.1156 0.4713 0.1356 0.7281 0.3127
Table 2 Neuronal subtype cell counts in Ctr-Q33 hiPSC-derived neuronal cultures at 23 and 37 DIV
Ctr Q33 DARPP-32 DARPP-32/Map2b Ctip2 (25B6) DARPP-32/Ctip2 Map2b GABA/Map2b TH/Map2b TBR1/Map2b
DIV 23 37 23 37 23 37 23 37 23 37 23 37 23 37 23 37
Diff 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
CSs 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Mean 0.3 6.3 0.2 6.0 61.8 54.8 0.1 5.9 97.0 94.5 50.4 29.8 19.3 35.6 3.9 7.1
SD 0.1 1.7 0.1 0.6 24.1 19.1 0.1 1.8 1.4 7.8 15.9 11.5 3.3 10.7 0.6 0.8
SEM 0.1 0.8 0.0 0.3 12.0 9.5 0.1 0.9 0.7 3.9 8.0 5.7 1.6 5.4 0.3 0.4
P value 0.0062* 0.0034** 0.75 0.0072* 0.0072* 0.0072* 0.0072* 0.0072*
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Figure S11, together with S12, details the neuronal properties
of each group, including the firing and bursting features. Neurons
from groups G5 and G8 displayed greater firing activity com-
pared with neurons of groups G1–G4. Neurons from group G5
elicited abundant spikes (mean of 320 ± 75 spikes per neurons), a
high frequency of 0.5 Hz and a low ISI of 1.91 s. Neurons from
G7, G8 and G6 also showed high spontaneous activity with a
mean of 182 ± 27, 112 ± 18 and 79 ± 16 spikes, respectively.
Neurons included in these groups fired spikes at relative high
frequency values in the range 0.1–0.3 Hz and, therefore, low
ISI of 5–8 s (Fig. S11a–c). Conversely, neurons from G1 to G4
groups (60% of the neurons) elicited a low number of spikes (<
60 spikes per neurons), at low frequencies < 0.1 Hz and high ISI
> 10s (Fig. S11a–c).
Practically all neurons, regardless the group, exhibited
bursting features. The only exception was group G4, in which
about 50% of the neurons were non-bursting. We thus con-
cluded that differentiation of the Ctr-Q33 line procured intrin-
sically bursting neurons. However, bursting patterns were not
uniform (Fig. S11d–h, i). Groups G5 and G7 (8% of the pop-
ulation) displayed strong bursting activity with about 40–60
bursts along the recording time, which provided a typical IBI
of 10–16 s (Fig. S11d and e). Neurons from groups G1 to G3,
together with the bursting neurons of G4 (totalling 60% of the
population), showed a weak bursting activity with a mean of
only 1–7 bursts and intervals greater than 40 s (Fig. S11d and
e). The remaining groups G6 and G7 (32% of the population)
displayed intermediate bursting values, in the range 7–17
bursts per neurons that provided IBIs in the range 27–60 s.
Concerning burst structure (Fig. S11f–h), Ctr-Q33 neurons in
general fired a mean of 2 spikes per neuron within a burst, and
with an interval of 500–800 ms. Groups G5 and G7 were an
exception, and showed more spikes at lower intervals. These
groups also displayed slightly longer bursts with a mean duration
of 8.6 and 7.7 s, respectively (Fig. S11h). For statistic compari-
sons of each feature between groups, see Fig. S13.
Putting together this group classification with the PCA anal-
ysis outlined above, we note that the “low firing neurons” corre-
spond to groupsG1 toG4 and comprise 60%of the neurons (Fig.
S13). The “intermediate firing neurons” correspond to groupsG6
and G8 and comprise 32% of neurons (Fig. S14). The “highly
firings neurons” are the remaining groups G5 and G7 and com-
prise 8% of the neurons (Fig. S15). Thus, the differentiation of
the Ctr-Q33 line not only led to spontaneously active neurons but
also orchestrated a network in which different kinds of activity
patterns could be observed.
Ligand-Gated Receptors Are Expressed
by Ctr-Q33-Derived Neurons at 37 DIV
We performed a screening of several NT receptors by quanti-
tative gene expression analysis along Ctr-Q33 hiPSC neuronal
differentiation (Fig. 14). Regarding the excitatory Glu
receptors, the three main NMDRAs subunits, GRIN1 (NR1),
GRIN2A (NR2A) and GRIN2B (NR2B), and the AMPA sub-
unit GRIA1 (GluR11) were induced by Ctr-Q33 hiPSC-de-
rived cultures at DIV 37 (Fig. 14a). GRIN2D (NR2D) and
GRIN3B (NR3B) along with other AMPA receptor subunits
were expressed through the differentiation but they did not
show significant changes in expression (Fig. S17a). GRIA2
subunit was found from DIV 8 onwards but the expression
remained similar along all DIVs (Fig. S17b). For kainate re-
ceptors, Ctr-Q33 neurons upregulated the expression of
GRIK4 (KA-1) at DIV 37 compared with 4–16 DIVs (Fig.
13a). GRIK3/4/5 gene expression was detected along differ-
entiation, but with similar values across DIVs (Fig. S17).
GRIK1 was detected from DIV 4 onwards but without chang-
es (Fig. S17b).
Ctr-Q33 neurons upregulated the expression of GABR-A2/
B1/D and G2 genes at 37 DIV (Fig. 14b). Also, neurons
started to express the GPCRs tachykinin receptor TACR1
(NK1R) at 12 DIV and afterwards it became upregulated at
23 DIV and 37 DIV (Fig. 14c). The Gly receptor subunit
GLRA2 was induced at 37 DIV compared with 8 DIV and
12 DIV (Fig. 14d). Ctr-Q33 neurons expressed the excitatory
serotonergic 5-HT receptors, Na+-K+ 5-HT channel HTR2A
and Gq/G11-GPCRs HTR3A (Fig. 14e). The HTR2A recep-
tor was detected from 4 DIVonwards and it was induced at 37
DIV. Conversely, HTR3A gene was expressed at the begin-
ning of differentiation up to 12 DIVwith an upregulation peak
at 8 DIV. The differentiation of Ctr-Q33 hiPSCs resulted in the
downregulation of the excitatory ATP-gated P2RX2 gene at
37 DIV compared with 0 DIV (Fig. 14f).
Neuronal Functional Maturation of hiPSC-Derived
Neurons Is Facilitated by the Expression of K+, Na+,
Ca2+ and Cl-ion Channels
We also analysed the expression of voltage-gated (VG) and
ion-gated channels along Ctr-Q33 hiPSC neuronal differenti-
ation (Fig. S16). The differentiation of Ctr-Q33 hiPSCs pro-
moted the upregulation of the VGNC SCN2B (Navβ2) at 37
DIV. Conversely, the SCN4A (Nav1.4) was downregulated at
8 and 12 DIVs compared with 0 DIV, and the SCN8A was
downregulated at 8 DIV compared with 37 DIV (Fig. S16a).
The neuronal differentiation of Ctr-Q33 hiPSCs also down-
regulated the expression of VG-Cl− channels CLCN1 and the
electroneutral K+/Cl− cotransporter SLC12A4/KCC1 genes
(Fig. S16b and c, respectively). The neuron-specific K+-Cl−
cotransporter 2 KCC2 (SLC12A5) gene was detected in Ctr-
Q33 neurons along all DIVs but it did not experience changes
on gene expression (Fig. S17).
In addition, the neuronal differentiation of Ctr-Q33 hiPSCs
promoted the expression of several VG-K+ channels including
(1) the A-type rapid inactivating KCNA4 (Kvα1.4); (2) the
slowly/non-inactivated delayed rectifier KCNA1 (Kv1.1) and
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KCNH1 (Kv10.1); (3) the inward rectifiers KCNH2 (Kv11.1);
and (4) the ATP-sensitive KCNJ11 (Kir6.2). All four subunits
were induced at 37 DIV (Fig. S16c). Moreover, the resting
membrane potential (RMP)-related KCKK2 subunit was up-
regulated at the progenitor’s stage at 16 DIV compared with
0–12 DIV, and the KCNK5 subunit was downregulated at 16
DIV compared with 0 DIV (Fig. S16c). Concerning VGCC,
Ctr-Q33 neurons displayed higher expression of (N)-
CACNA1B (Cav2.2) and L-type CACNA1C (Cav1.2) genes
at 23 DIVand 37 DIV compared with 0 DIV to 16 DIV. The β
subunits CACNB4 and the calcium/calmodulin-dependent
protein CAMK2A genes were also induced at 37 DIV (Fig.
S16e). Ctr-Q33 neurons also expressed the CAMK1G,
CAMK4 and CASK genes but their levels were unaltered
along differentiation (Fig. S17a).
Mouse Striatal Environmental Cues Promote
the Differentiation of hNPCs to Striatal Projection
Neurons at 3 Months Post-Transplantation
Finally, we investigated the differentiation potential of hPSC-
derived NPCs in vivo.We conducted a number of experiments
in which GFP-expressing Ctr-Q33 hiPSC-derived NPCs at 16
DIV were transplanted into the neonatal mouse striatum (Fig.
S19a). We evaluated the differentiation and integration of
grafted human cells at short-term (1 month) and long-term
(3 months) post-transplantation (PST) time points. A total of
18 neonatal mice were transplanted with one dying from com-
plications related to surgery, while the other 17 mice reached
adulthood without any significant alterations being observed
(94% survival). In the 17 surviving mice, we observed no sign
of teratoma formation in any animal. At 1 month PST, Ctr-
Q33-GFP cells showed good survival (total number of HNA+
cells, 3948 ± 195; % surviving cells, 26 ± 1%; n = 6). They
were mainly located within the core of the graft and differen-
tiated into striatal neurons, as they were labelled for MAP2,
CTIP2 and DARPP-32 (Fig. 15a–c). Cell counts (Fig. S19c)
revealed a high proportion of MAP2+ cells (80 ± 4%) at
1 month PST (Fig. 15d). Remarkably, 89 ± 3% of transplanted
hNPCs showed CTIP2 nuclear staining and 7 ± 2% expressed
DARPP-32 (Fig. 15e and f, respectively). By 3 months PST,
the percentage of Ctr-Q33-GFP-derived neurons positive for
these markers was slightly reduced, with 82 ± 5% of CTIP2+
cells and 5 ± 1% of DARPP-32+ cells (Fig. 15e and f). At this
time point, the average graft volume was 91 ± 4 × 106 μm3
(Fig. 16a and Fig. S19b) and human cells located outside the
core of the graft reflected increased migration (Fig. 16d, Fig.
S19b and Fig. S20c). Most importantly, Ctr-Q33-GFP
hNPCs-derived neurons were able to project long axons to-
wards the external globus pallidus, a native striatum target
(Fig. 16b and c and Fig. S20a and b). Electron microscopy
analysis of these projections by means of GFP immunogold
labelling revealed numerous synaptic connections between
host and grafted neurons, indicating that functional integration
of the transplanted cells had occurred (Fig. 16e–g). Human
neurons established symmetric (inhibitory) synapses (Fig.
16e) and received asymmetric (excitatory) synaptic inputs
(Fig. 16f and g) from host cells, mimicking MSN circuitry
within the basal ganglia. It is of note that of the population
of HNA+ cells found in the mouse striatum, 76 ± 5% main-
tained GFP expression at 3 months PST.
Robustness of the Protocol
At the time of revision of this manuscript, this neuronal
differentiation protocol has been performed a total of
399 times, 165 times with hESC lines (41%) and 234
times with hiPSC lines (59%). The protocol has been
conducted by different staff members of our centre, in-
cluding PhD students, technicians and post-doctoral re-
searchers. Although differentiation was not deeply char-
acterized on all occasions as described here, on 349
occasions (87%), a mature neuronal phenotype was
achieved, while failure only occurred on 50 occasions
(13%). These results demonstrate the robustness of the
protocol.
Discussion
The neurogenesis of hPSCs is a complex process com-
prised by several phases and signals. This includes the
neural fate specification of hPSCs, the proliferation and
specification of NPCs to region-specific progenitors and
their terminal differentiation to subtype-specific neurons.
The neuronal differentiation is accompanied by neurites
and axon outgrowth, synapse formation and maturation
that finally shape the neuronal circuit. Here we modelled
Fig. 10 Ctr-Q33 and GEN-Q18 hPSC-derived TH+ and Tbr1+ neurons.
Proportion of TH+ cells relative to MAP2b + in Ctr-Q33 (black) and
GEN-Q18 (grey) at 23 and 37 DIV and b representative TH (green)
staining along with MAP2b (red) and DAPI (blue) at both DIVs by Ctr-
Q33 hiPSC-derived neuronal cultures. Triangular arrowheads point
intense TH+ neurons and spiky arrowheads highlight low TH+ neurons.
Scale bar 30 μm. c Proportion of Tbr1+ cells relative to MAP2b + in Ctr-
Q33 (black) and GEN-Q18 (grey) at 23 and 37 DIVand d representative
Tbr1 (green) staining along with MAP2b (red) and DAPI (blue) at both
DIVs by Ctr-Q33 hiPSC-derived neuronal cultures. Triangular
arrowheads point intense Tbr1 + neurons and spiky arrowheads point
low Tbr1 + neurons. Scale bar 30 μm. (Mean ± SEM; two-way
ANOVA followed by Tukey’s multiple comparison test, ns P > 0.05).
Quantitative DAergic- and glutamatergic-related gene expression profile
along (e–g and i) Ctr-Q33 and (h and j) GEN-Q18 neuronal
differentiation. (Mean ± SEM; one-way ANOVA followed by Tukey’s
multiple comparison test, relative to 0 DIV *P < 0.05, **P < 0.01,
***P < 0.001; to 8 DIV + P < 0.05, ++ P < 0.01, +++ P < 0.001; to 16
DIV $ P < 0.05, $$ P < 0.01, $$$ P < 0.001)
b
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the in vitro differentiation of two hPSC lines from
pluripotency to forebrain mature neurons. The neuronal
differentiation generated enriched-ventral telencephalic
neuronal progenitors which showed a successful in vitro
functional maturation and in vivo integration.
Patterning of hPSCs to Telencephalic Neural
Progenitors
The initial stages of the differentiation protocol rapidly and
efficiently induced a neuroectodermal identity and by 8 DIV
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neuroepithelial rosettes, the in vitro two-dimensional equivalent
of the neural tube had formed. This is faster thanwith other hPSC
neural differentiation protocols where 10–14 days are required
for rosettes to form from hPSCs. For example, Delli Carri and
colleagues showed neural rosettes 15 days after induction [29],
and Aubry and colleagues after 21–23 DIV [30].
The neuroepithelial cells were successfully specified to a
forebrain NPC identity and not a more posterior identity as
shown by expression of the forebrain marker FOXG1 and the
absence of expression of midbrain, hindbrain and spinal cord
markers. A ventral forebrain NPC fate was then acquired by
the majority of cells based upon the expression of the Dlx
family of transcription factors and the transcription factor
EBF1 which play key roles in the specification of distinct
populations of ventral telencephalic progenitors. This ventral
specification was achieved solely by inhibiting dorsal BMP
and Wnt signals [31, 32]. The ventralising morphogen SHH
was omitted in an attempt to avoid the specification of ventral
MGE-interneuron progenitors at the expense of striatal neuron
progenitors [33–35]. FOXG1 expression may have con-
tributed to the observed efficient ventral NPC specifica-
tion as it is known to inhibit canonical Wnt signalling
which specifies a dorsal fate. A small population of
Pax6-expressing NPCs was also observed which may
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Fig. 11 Quantification of a DARPP-32+/ MAP2b+, b CTIP2+ and c
double DARPP-32+/CTIP2+ in Ctr-Q33 (black) and GEN-Q18 (grey)
hPSC-derived cultures at 23 and 37 DIV (Mean ± SEM; two-way
ANOVA followed by Tukey’s multiple comparison test, *P < 0.05,
**P < 0.05). Representative images for DARPP-32 (green) and CTIP2
(red) at d 23 DIV and e 37 DIV (Arrowhead points out double-labelled
neurons and arrow single-labelled-CTIP2 nucleus). Scale bar 30 μm
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be suggestive of a dorsal forebrain identity [36].
Increasing slightly the concentration of the BMP and
Wnt signalling inhibitors could avoid the formation of
these dorsal NPCs and potentially produce a pure pop-
ulation of ventral NPCs. However, Pax6 is also
expressed in neuroepithelial progenitors [27]. Given that
these Pax6-expressing cells also expressed ventral
markers and that a low number of Tbr1-expressing neu-
rons were observed, this suggests that most of the
Pax6+ cells are neuroepithelial progenitors.
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Fig. 12 Gene expression profile of striatal MSN-related genes by Ctr-
Q33 hiPSC and GEN-Q18. a–d PPP1R1B/DARPP-32 and CALB1, e–h
BCL11B/CTIP2 and ZNF503, i–lADORA2A and PENK andm–t TAC,
OPRM1 and dopamine receptors DR1 and DR2 along. Mean ± SEM;
one-way ANOVA followed by Tukey’s multiple comparison test,
relative to 0 DIV *P < 0.05, **P < 0.01, ***P < 0.001; to 8 DIV + P <
0.05, ++ P < 0.01, +++ P < 0.001; to 16 DIV $ P < 0.05, $$ P < 0.01, $$$
P < 0.001
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The DLX family of transcription factors and EBF1 are
involved in the specification of distinct populations of ventral
NPCs and neuroblasts. The DLX family is involved in spec-
ifyingMSNs of the indirect pathwayMSNs while EBF1 plays
a role in specifying direct pathwayMSNs [37–39]. At 16 DIV,
more DLX-expressing NPCs were observed than EBF1-
expressing NPCs and this difference may be attributable to
the different expression time windows of these transcription
factors during striatal neurogenesis. Whereas DLX-1 and 2 are
expressed by proliferative NPCs in the VZ and SVZ, EBF1 is
expressed later by NPCs as they differentiate to postmitotic
neuroblasts in the MZ [40–42]. Thus, the in vitro expression
patterns of transcription factors involved in striatal develop-
ment mirror the patterns observed in vivo indicating that the
differentiation protocol recapitulates key aspects of
neurodevelopment.
Specification of hPSC-Derived NPCs to Postmitotic
Telencephalic Neurons
Themain affected area of the brain in HD is the striatum due to
the degeneration of the GABAergic MSNs. A cell therapy
approach to replace the degenerated MSNs is a viable strategy
to treat HD and for this reason, we have developed the ventral
forebrain neuron differentiation protocol described here in ad-
dition to using it as a platform to study neurodevelopment in
both healthy and disease contexts.
This protocol efficiently generates neurons with almost
all cells acquiring a neuronal identity by the end of the pro-
tocol. This compares favourably to other striatal neuron dif-
ferentiation neurons where a mixture of cell types including
neurons is often obtained [29, 30, 43]. These neurons ex-
press a wide range of ion channels, NMDA receptors and
synaptic-associated genes indicating that they are function-
al at both the individual neuron and network level.
Furthermore, these neurons display a large amount of
sprouting and arborisation, as well as containing spine-like
structures as has been shown previously [18]. This protocol
produces neurons from hPSCs in just 37 days which is faster
than other striatal differentiation protocols where longer pe-
riods of time are required (see Fig. 18). The protocol devel-
oped by Arber and colleagues [35] requires a similar period
of time to acquire a neuronal phenotype (37–43 DIV).
However, whereas Arber et al. demonstrate firing in a low
number of neurons after 93 DIV [35], here we showed ac-
tivity in 84% of the analysed neurons at 37 DIV.
a
3
c
2
1
Fraction of 
neurons per K-means group
b c
33.60%  G4 17.80%  G8
14.20%  G612.00%  G2
10.20%  G3 7.10%  G7
4.00%  G1 1.10%  G5
Fig. 13 Segregation of Ctr-Q33
hiPSC-derived neurons by its
spontaneous activity at 37 DIV. a
PCA plot from active neuronal
population segregated based on
the neuronal features and
clustered in 8 groups
(differentially coloured). b
Individual fluorescence trace
(ΔF/F0) (t) from neurons 1–3
from a PCAwith different activity
patterns. c Pie plot of the fraction
of neurons in each group (G1–
G8)
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MSNs are commonly defined by the co-expression of
CTIP2 and DARPP-32 [29, 44]. Although a high number of
CTIP2-expressing neurons were observed with this protocol,
the number of neurons co-expressing the two proteins was
6%. Published MSN differentiation protocols vary both in
their reproducibility and in the amount of MSNs that they
produce, ranging from 4 to 60% (see Fig. S18 and references
therein). Factors that may contribute to this variability include
the PSC lines that are used, how those PSC lines are main-
tained prior to differentiation and differences between the pro-
tocols including how and when signalling pathway activity is
modified. Other sources of variability include the antibodies
that are used to detect DARPP-32, their sensitivity and also
the isoforms of DARPP-32 that these antibodies detect. No
consensus exists on which DARPP-32 antibody is the best for
detecting MSNs in vitro and as such different groups use
different antibodies which recognise different epitopes [28].
Different human DARPP-32 isoforms are known to exist with
the isoforms that are expressed varying according to the
neurodevelopmental stage. Furthermore, DARPP-32 has the
potential to undergo several post-translational modifications
(PTMs) depending on the state of the cell and the signals
which are being received [28] which further complicates
antibody-mediated detection. Taking these factors together
illustrates the difficulties associated with using DARPP-32
as a robust marker for in vitro differentiated MSNs.
Given the large number of cells that express either CTIP2
or GABA, and the doubts associated with using DARPP-32 as
MSN marker, we are of the opinion that there are more than
6% MSNs in the cultures. We propose that these additional
MSNs either express isoforms or contain PTMs that are not
detectable with the DARPP-32 antibody used here.
Alternatively, DARPP-32may be expressed at a low level that
is below the detection threshold of the antibody. The hypoth-
esis that there are more MSNs present in the cultures than are
detected by the antibody is strengthened by the observed ex-
pression of several other genes that label MSNs at the later
stages of the differentiation protocol.
A small percentage of glutamatergic cortical neurons was
detected based on the expression of known cortical markers.
This low abundance correlates with the small amount of Pax6-
expressing dorsal NPCs that was observed at an earlier stage
of the differentiation. We also consider the possibility that a
fraction of the neurons expressing CTIP2 but not DARPP-32
is also cortical neurons as in addition to being expressed in the
striatum, it is also expressed in layer 5 of the cortex [45, 46].
An abundant amount of tyrosine hydroxylase (TH)-ex-
pressing neurons was also detected. Although TH is a marker
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c
Fig. 14 Quantitative gene expression matrices of ligand ion-gated
receptors expression by Ctr-Q33-derived cultures along the neuronal
differentiation (DIV vs. DIV). a Glu, b GABA, c tachykinin, d glycine,
e serotoninergic and f purinergic receptors along Ctr-Q33 hiPSC neuronal
differentiation. One-way ANOVA followed by Tukey’s multiple
comparison test was performed between DIVs (0 to 37). Coloured
matrices represent all possible comparisons on the diagonal (blue box;
DIVon which the statistical test is done for all the multiple comparisons);
non-expressing genes are represented as grey boxes. Colour boxes are
expressing genes with P < 0.05. Upregulated and downregulated genes
are represented by red and green respectively with increasing three
colour-scale intensities for P ≤ 0.5, P ≤ 0.005 and P ≤ 0.0005 respectively
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1 month PST
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MAP2
CTIP2
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c
a Merge
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MergeHNA DARPP-32
Fig. 15 hNPCs transplanted into the mouse neonatal striatum
differentiate into striatal neurons. Pictures of Ctr-Q33-GFP hiPSC-
derived neurons at 1 month PST labelled with GFP or HNA (green)
and a MAP2, b Ctip2 or c DARPP-32 (red). Cell counts for MAP2 d at
1 month PSTand CTIP2 e and DARPP-32 f at 1 and 3 months PST. Scale
bars 50 μm
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of midbrain dopaminergic neurons, in this case, it is unlikely
that these neurons have this identity as during differentiation,
we did not detect expression of Pax2 which is necessary for
midbrain neurogenesis [47]. Furthermore, midbrain dopami-
nergic neuron differentiation requires SHH, FGF8 andWnt/β-
catenin signalling which are either inhibited or absent in this
protocol [48]. These TH-expressing neurons are likely to be a
subpopulat ion of str ia ta l interneurons as during
neurodevelopment, these interneurons are generated by the
medial ganglionic eminence [49, 50] which is adjacent to the
GFP/CTIP2
St
GP
3 months PST
b cGFP/DARPP-32
St
a
e GFP GFPf
g
200 nm
GFP/CTIP2
1 μm
Pre
Post
Syn
Post
Pre
Syn
d GFP/CTIP2
Fig. 16 Transplanted hNPC-derived neurons project towards MSN
targets and establish synaptic connections at 3 months post-
transplantation. a Low-magnification picture of a coronal section of the
mouse striatum showing grafted Ctr-Q33-GFP human cells at 3 months
PST. b–d Sagittal sections of the mouse striatum showing CTIP2+ human
cells extending GFP+ projections towards the external globus pallidus
area. e–g Ultra-thin sections at the mouse striatum-globus pallidus level
showing TEM images of human neurites (dotted lines), identified by
means of GFP immunogold labelling (black arrows). e Human neurite
(pre) establishing a symmetric inhibitory synapse (white arrowheads)
with a host mouse cell (post). f Human neurite (post) receiving an
asymmetric excitatory synapse (white arrowheads) from a host mouse
cell (pre). g High magnification of the postsynaptic density of the
synapse (white arrowheads) illustrated in f. St striatum; GP globus
pallidus; Pre presynaptic; Post postsynaptic; Syn synapse. Scale bars
200 μm in a; 50 μm in b, c, d
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lateral ganglionic eminence that generates the MSNs. Gradients
of the same signallingmolecules are involved in generating these
regions, and many of the same transcription factors are involved
in the development of both of these regions [51]. From an in vitro
perspective, slight variations during the patterning stage of the
differentiation protocol in the concentrations of the small mole-
cules received by individual cells and the processing of these
signals could drive them to become MGE NPCs instead of
LGENPCs. The striatal interneuron identity hypothesis was con-
firmed when we observed co-expression of TH and GABA as
has been described previously for a subpopulation of striatal
interneurons [52]. This GABAergic striatal interneuron identity
was further supported by the observed expression of various
interneuron-related genes at the transcriptomic level at the same
differentiation stage.
Synaptic and Functional Maturation of hPSC-Derived
Telencephalic Neurons
Effective in vitro neuronal differentiation protocols require the
production of functionally mature neurons where gene expres-
sion profiles and functional properties mirror those of the cor-
responding endogenous neuronal types. Functional matura-
tion requires the expression of a range of ion channels, recep-
tors, intracellular signalling components and synaptic
function-related genes whose expression levels may alter as
maturation proceeds. The expression of ion channels, recep-
tors and intracellular signalling components contributes to the
intrinsic functional properties of individual neurons while
functional neuronal network development relies upon expres-
sion of the synaptic machinery.
The expression of ligand-gated channels and VGCs con-
tributes to the acquisition of passive and active neuronal prop-
erties, including excitability and the ability to elicit and trans-
mit action potentials [53]. We observed upregulation of the
RMP-related channel subunit, which is likely to be at least
partly responsible for the negative resting membrane potential
of hPSC-derived neurons that we have reported previously
[18]. Furthermore, expression of voltage-gated sodium chan-
nels (VGNCs) was also observed which correlates with the
ability of hPSC-derived neurons to display VGNC currents
[23]. At the later stages of neuronal differentiation, we ob-
served expression of several voltage-gated potassium chan-
nels (VGKCs) and voltage-gated calcium channels (VGCCs)
that are responsible for driving functional maturation.
Previous work showed that the blockage of VGCCs results
in a dramatic suppression of action potentials by hPSC-
derived neurons and a decline in the RMP [45]. Taken togeth-
er, the expression of these ion channel-related genes contrib-
utes to neuronal electrophysiological maturation and indicates
that this protocol produces functionally maturing neurons.
Neuronal differentiation and maturation also require intra-
cellular calcium transients (iCa2+) and calcium-mediated
signalling events. iCa2+ can arise from twomain sources, from
extracellular (eCa2+) influx which is triggered by growth fac-
tors or NT-mediated depolarization, or from the release of
iCa2+ stores [54]. Increased iCa2+ concentration initiates
downstream signalling cascades that result in modulation of
gene expression [55], receptor trafficking [56] and synapse
remodelling [55], among other functions. Thus, it is essential
that in vitro differentiated neurons develop a functional calci-
um sensing and signalling system.
In most CNS neurons, Ca2+ influx is mediated by the open-
ing of surface L-Type VGCCs, and also AMPA and NMDA
receptors. The upregulation of such genes was observed at the
later stages of our differentiation protocol. Other VGCCs,
specifically the N- and P/Q-types, are highly expressed at
the presynapse where they mediate Ca2+-dependent presynap-
tic NT-vesicle release to the synaptic cleft via direct interaction
with SNAREs and vesicle-adapter proteins [57, 58]. In re-
sponse to an incoming action potential, presynaptic VGCCs
open and allow iCa2+ levels at the terminal buttons to rise from
basal nanomolar concentrations to over 50 μM [59].
Expression of N-type VGCCs and several SNARE proteins
was observed in our neuronal cultures suggesting that these
neurons have functional Ca2+-mediated signalling pathways
and are developing functional synapses. Further evidence of
Ca2+-mediated neuronal maturation was inferred from the ob-
served expression of the auxiliary β4-L-type VGCC. This
subunit modulates the surface expression and gating of the
α1-VGCC subunit, and promotes neuronal maturation by
repressing the action of the heterochromatin protein 1 gamma
(HP1γ) [60, 61]. β4-VGCC subunit expression at the later
stages of the differentiation protocol might mediate Ca2+-de-
pendent HP1γ repression and facilitate neuronal maturation.
Taken together, we conclude that these neurons have function-
al Ca2+ signalling and homeostatic systems that have the po-
tential to produce iCa2+ transients which are essential for neu-
ronal maturation.
Synaptic maturation requires the expression of presynaptic-
related proteins, including vesicle-associated proteins, and
postsynaptic-related proteins, such as NMDARs and AMPA
subunits. Such gene expression patterns were observed at the
later stages of the differentiation protocol, indicating that syn-
apse formation and maturation were occurring in our neuronal
cultures which in turn would result in the formation of neuro-
nal networks. Previously we showed that hPSC-derived neu-
rons responded to excitatory (Glu) and inhibitory (GABA)
NTs and that they evoked miniature postsynaptic excitatory
and inhibitory currents in respond to Glu and GABA, respec-
tively [18]. In addition, we showed that the hPSC-derived
neurons were sufficiently mature to perform the GABA
switch, where GABA evokes miniature inhibitory currents
instead of excitatory currents which is characteristic of imma-
ture neurons [18]. This prior work complements the observa-
tions of synaptic maturation described here. In the present
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work, however, dynamic expression of the genes responsible
for the GABA switch was not detected. Neither upregulation
of the neuron-specific cotransporter KCC2 nor downregula-
tion of the immature neuron-specific NKCC1 cotransporter,
which is responsible for the reduction of intracellular iCl−
ions, was observed [62–64]. This discrepancy may be due to
the fact that in this work, gene expression was studied at the
neuronal population level where different neuronal types at
different maturation stages are present. A population level
analysis may mask the changes of gene expression associated
with the GABA switch if it only occurred in a subset of the
total population.
To validate the apparent functionally mature state of the
neurons indicated by the gene expression studies, we per-
formed high-speed somatic Ca2+ imaging at the endpoint of
the protocol. We found that a high proportion of neurons
displayed spontaneous iCa2+ transients. These transients were
characterized by a fast Ca2+ rise followed by a slow decay, a
hallmark of elicited action potentials [65]. Neuronal activity
typically appeared in the form of bursts, which corresponds to
trains of action potentials, although the degree of activity var-
ied between neurons. Analysis of the spontaneous firing neu-
ronal activity identified three main groups which varied ac-
cording to their activity and were termed “high firing” (HF),
“intermediate firing” (IF) and “low firing” (LF) neurons.
HFNs comprised 8% of the neurons which fired strong burst-
ing events every 10 s. In contrast, LFNs comprised 60% of the
neurons, exhibited weak bursting every 40 s or more, and in
general tended to elicit single spike events at low rate. The IF
neurons, which comprise the remaining 32%, displayed an
intermediate behaviour firing between 10 s and 40 s. LFNs
are likely to be functionally immature neurons as they very
rarely generated bursts of spikes which is a feature of more
mature neurons.
Various reasons are likely to contribute to the variety of
neuronal activity patterns observed here. As described
above, different neuronal types are present within the same
culture and each neuronal type is likely to have a different
activity pattern and maturation rate. Furthermore, the rate of
neuronal maturation is unlikely to be uniform, and thus it is
probable that neurons of the same type are at different mat-
uration stages both at the individual cell and network level
which would contribute to the heterogeneous activity state.
Also, given that both glutamatergic and GABAergic neu-
rons are present in the same culture, similar cells within a
culture may experience different local conditions in terms of
excitatory and inhibitory inputs which would further con-
tribute to variable activity. This protocol produces neurons
in a highly efficient manner, but the absence of astrocytes
could also contribute to the abundance of weakly firing
neurons. Astrocytes have been shown to increase functional
maturation, potentiate the activity of developing neurons
and contribute to synapse formation [66–69].
At the neuronal circuitry level, we must bear in mind that
endogenous striatal neurons receive excitatory Glu inputs
from the cortex and thalamus and DA inputs from the
substantia nigra pars compacta. It has been shown that the
inhibition of cortico-striatal projections during synaptogenesis
alters MSNs maturation by reducing dendritic spine density
[67]. The addition of such inputs could have a positive impact
on in vitro striatal neuron differentiation and network forma-
tion. Thus, the development of a differentiation protocol with
integrated cortical and dopaminergic inputs could have a pos-
itive impact on in vitro striatal neuron differentiation and net-
work formation.
Based on the relevant gene expression and functional data,
in combination with previously published data [18, 19], we
conclude that the differentiation protocol produces functional
neurons with gene expression patterns similar to those ob-
served during functional neuronal maturation in vivo.
Striatal Neuronal Differentiation of hPSC-Derived
NPCs Within the Mouse Striatum and Integration
into Host Circuitry
The suitability of this protocol for use as part of cell therapy-
based treatments was evaluated by the transplantation of
hPSC-derived NPCs into the neonatal mouse striatum. In the
ideal scenario, which is fully compatible with a cell therapy-
based approach, transplanted NPCs should differentiate to the
desired neuronal type without excessive proliferation. These
neurons should then survive for a prolonged period and inte-
grate into the host circuitry.
The transplanted NPCs differentiated to neurons within
1 month of grafting, with no increased number of
transplanted cells being observed by 3 months post-trans-
plantation. This demonstrates that the transplanted NPCs
integrate local signals to exit the cell cycle and commit to
a neuronal identity with a minimal risk of graft overgrowth.
This compares favourably to previous work where exces-
sive graft overgrowth was observed following the transplan-
tation of hPSC-derived NPCs into mouse striatum [29, 30].
The majority of the NPC-derived neurons acquired a striatal
identity based on the expression of known striatal neuron
markers, which correlates well with the in vitro neuronal
gene expression data. These neurons also showed higher
survival and terminal differentiation in the mouse striatum
compared with other studies [68].
A subset of the neurons displayed polarised innervation
towards the external globus pallidus (GP) as occurs with en-
dogenous MSNs, indicating that they are integrating into the
relevant host circuitry. During development, axon outgrowth
and projection are highly regulated by cell-autonomous mech-
anisms and also by extracellular cues [69, 70]. Several TFs,
including CTIP2, ISL1 and EBF1, have been implicated in
striatonigral MSN axon outgrowth [37, 71, 72]. Expression
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of these TFs was observed in hPSC-derived neurons both
in vitro and post-transplantation, indicating that NPCs are cor-
rectly patterned prior to grafting. The combination of NPC
intrinsic properties acquired during in vitro differentiation,
together with the integration of signals from the host environ-
ment, led transplanted cells to behave in a similar manner to
host striatal neurons. Furthermore, hNPC-derived neurons
established inhibitory synapses (likely GABAergic) and re-
ceived excitatory synaptic inputs (likely glutamatergic) from
host neurons. This mirrors the input-output circuitry of MSNs
and suggests that hNPC-derived neurons are also functional
within the host circuitry. Remarkably, little evidence of archi-
tecturally appropriate neuronal integration, much less circuit
reconstruction, has been reported after transplantation of
hESC or hiPSC-derived MSNs into the striatum [73]. Based
on the behaviour of the transplanted NPCs, we conclude that
our differentiation protocol successfully meets all the criteria
for use in cell therapy-based strategies.
Conclusion
Here we perform an in-depth characterisation of an in vitro dif-
ferentiation protocol that produces functional ventral forebrain
neurons, including medium spiny neurons, from hPSCs in just
37 days. We observe that the protocol is robust and reproducible,
and that the dynamic changes in gene expression that occur
during the protocol mirror those observed during human
neurodevelopment. The neurons that are produced in vitro are
functionally mature while the protocol is also compatible with
cell therapy-based approaches following the successful trans-
plantation of hPSC-derived NPCS which undergo neuronal dif-
ferentiation and integrate into the host brain circuitry.
Given all of these characteristics, we conclude that this proto-
col is an ideal platform for the in vitro study of both
neurodevelopment and neuronal diseases, including those neuro-
degenerative disorders that cause alterations during neurogenesis.
Due to its robust, reproducible and rapid nature, it is also ideal for
use as a drug screening and developmental toxicology platform.
Finally, we believe that this protocol has great potential as the
basis of cell therapy-based strategies to treat neurodegenerative
diseases where there is currently no cure.
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